How often is xgeva injected for bone mets?

How often is Xgeva given for bone metastases?

Xgeva (denosumab) is typically injected once every 4 weeks for patients with bone metastases.

Does the dosing schedule change after starting?

In standard practice, the 4-week dosing interval continues while the patient remains on treatment. The exact plan can be adjusted based on the treating clinician and patient factors, but the usual schedule stays at monthly dosing.

Is it different for the first dose or for other indications?

Xgeva dosing frequency depends on the indication, and dosing schedules can differ from regimens used for other conditions (for example, preventing skeletal-related events in different clinical settings). For bone metastases specifically, the common interval is every 4 weeks.

What do patients need to know between injections?

Between injections, clinicians monitor for treatment-related risks such as low calcium (hypocalcemia) and jaw bone problems (osteonecrosis of the jaw). Patients are usually advised to take calcium and vitamin D unless their clinician directs otherwise.

What if an injection is missed?

If a scheduled dose is missed, patients should contact their oncology team to reschedule. The goal is to return to the regular dosing interval as directed by the prescriber.